The immune system functions to prevent and retard the local establishment or systemic dissemination of bacteria, viruses, fungi, and protozoa. Furthermore, it must accomplish this task without excessive inflammation or the development of autoimmunity. The immune system has four primary components:
- 1.
Antibody-mediated immunity (humoral or B cell immunity) is mediated by bone marrow-derived B lymphocytes and plasma cells (differentiated antibody-producing cells), which release antibodies (immunoglobulins) into secretions, plasma, and interstitial spaces. Antibodies work to opsonize and promote phagocytosis of organisms, neutralize toxins, and lyse pathogens (with the aid of complements).
- 2.
Cell-mediated immunity (T cell immunity) is mediated by thymus-derived T lymphocytes (i.e., CD4 and CD8 T cells) that are activated by antigen-presenting cells (e.g., dendritic cells, macrophages) and antigens. Although T cells do not produce immunoglobulin, CD4 T cells are necessary for optimal B cell function. CD4 T cells also express cytokines that activate phagocytes to efficiently clear intracellular pathogens. CD8 T cells lyse virally infected cells.
- 3.
The phagocytic system consists of tissue macrophages and dendritic cells, as well as blood-borne monocytes and neutrophils. In response to specific signals, phagocytes ingest and kill invading microorganisms. Dendritic cells also serve as antigen-presenting cells for T cells.
- 4.
The complement system acts synergistically with antibodies and the remainder of the immune system to help clear microbial infections both directly (complement-mediated cytolysis) and indirectly (recruitment of phagocytic cells, opsonization of microbes).
The differential diagnosis for patients with recurrent infections is formidable in view of the complexity of the immune system. The different arms of the immune system are interconnected, thus similar infections may occur as a manifestation of phagocyte, humoral, cell-mediated, or complement disorders that can be inherited or acquired ( Table 41.1 ). Alternatively, highly characteristic infections can point to a defect in a particular arm of the immune system ( Table 41.2 ). Most patients with recurrent infections do not have an underlying identifiable primary immunodeficiency, but they frequently have allergic rhinitis, asthma, or other risks for recurrent infections ( Table 41.3 ). Because of the low probability of identifying a discrete immune defect, the primary physician faces the difficult decision about the extent of the evaluation and which patients merit a complete evaluation. In addition, other genetic defects in the immune system result in recurrent episodes of spontaneous inflammation (i.e., autoinflammatory disorders ), or immune dysregulation and autoimmunity , and these can often be mistaken as recurrent infections.
Disorder | Pathogen | Deficiency |
---|---|---|
Primary Immunodeficiencies | ||
Humoral immunodeficiency syndromes (predominantly B cell defects) | Bacterial pathogens, enteroviruses | Reduced phagocytic efficiency, failure of lysis and agglutination of bacteria, inadequate neutralization of virus and bacterial toxins |
Cellular immunodeficiency syndromes (predominantly T cell defects) | CMV, VZV, Strongyloides stercoralis; Mycobacterium, Listeria, Nocardia; Cryptococcus, Candida species; Pneumocystis carinii | Absence of or impaired delayed hypersensitivity response; absence of T cell cooperation for B cell synthesis of antibodies to T cell–specific antigens; absence of T cell cytokines that activate mononuclear phagocytes, failure of T cell clearance of viruses |
Complement Deficiencies | ||
C1, C2, C3, C4, and factor B | Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Klebsiella species | Defective chemotaxis and opsonization of microbes |
C5-C8 and properdin deficiencies | Neisseria meningitidis, Neisseria gonorrhoeae | Defective membrane attack mechanism |
Phagocyte Defects | ||
Neutropenia (ANC < 500/mm 3 ) | Pyogenic bacteria or fungi , Pseudomonas species , Staphylococcus aureus | Decreased neutrophil numbers |
Chronic granulomatous disease | Catalase-positive organisms, e.g., S. aureus, Serratia species, Burkholderia cepacia, Nocardia species , Candida species, Aspergillus species | Impaired neutrophil bactericidal activity secondary to impaired production of hydrogen peroxide |
Secondary Immunodeficiencies | ||
AIDS | CMV, VZV, adenovirus, HBV, Giardia lamblia, Entamoeba histolytica, Mycobacterium avium–intracellulare, Toxoplasma gondii, Mycobacterium tuberculosis, Cryptococcus neoformans, Pneumocystis jirovecii; Campylobacter, Candida, Isospora, Aspergillus, Nocardia, Strongyloides, and Cryptosporidium species | Retrovirus infections transmitted by bodily fluid impair T cell response, reduced T helper cell numbers |
Cancer | VZV, HSV, Escherichia coli; Pseudomonas, Klebsiella, Listeria, Cryptococcus, Pneumocystis, and Mycobacterium species | Neutropenia, lymphopenia, impaired cellular immunity |
Immunosuppression | HSV, VZV, CMV, EBV, hepatitis virus, Pseudomonas species, E. coli; Klebsiella, Acinetobacter, Serratia, Candida, Aspergillus, Mucor, and Cryptococcus species | Dependent on agent used, leads often to impaired cellular immunity and neutropenia, lymphopenia |
Transplantation | CMV, HSV, VZV, hepatitis virus, S. aureus; Pseudomonas, Klebsiella, Candida, Aspergillus, Nocardia , and Pneumocystis species; EBV | Related to use of immunosuppressive agents |
Malnutrition | Measles, HSV, VZV, Mycobacterium species | Impaired T cell function, reduction in complement activity |
I. Humoral Defects |
|
II. Combined B and T Cell Defects (Congenital, Acquired Immunodeficiency Syndrome, Immunosuppression Malignancies) |
|
III. Neutropenia (Severe Chronic Neutropenia, Aplastic Anemia, Myelosuppression, Myelophthisis Myelosuppressive Agents, Bone Marrow Transplantation) |
|
IV. Phagocytic Dysfunction |
|
V. Splenic Dysfunction (e.g., Asplenia, Sickle Cell Anemia) |
|
Predisposing Causes | Organism and Type of Infection |
---|---|
Alteration of Mucocutaneous Barriers | |
Indwelling Catheter | |
Central venous catheter (Broviac, Hickman) | Staphylococcus aureus ; S. epidermidis ; and Bacteroides , Candida , Pseudomonas species: bacteremia, fungemia |
Urinary catheter | Escherichia coli , Enterococcus species, Staphylococcus saprophyticus : pyelonephritis |
Tenckhoff catheter (continuous ambulatory peritoneal dialysis) | Staphylococcus epidermidis , S. aureus , E. coli , Pseudomonas aeruginosa , Candida species: peritonitis |
Cerebrospinal fluid shunts | S. epidermidis , S. aureus , diphtheroid, Bacillus species: meningitis |
Aspirated pulmonary foreign body | S. aureus , anaerobes: pneumonia, pulmonary abscess, empyema |
Burns | P. aeruginosa , S. epidermidis , Candida species: cutaneous lesions, sepsis |
Inhalation Therapy: Contaminated Solutions | P. aeruginosa, Serratia marcescens, Legionella species: pneumonia |
Surgical Wounds | |
Abdominal | Gram-negative bacteria, S. aureus, S. epidermidis, Candida species: peritonitis |
Nongastrointestinal | S. aureus, S. epidermidis, streptococci, gram-negative bacteria: wound abscess, sepsis |
Fistula-Sinus Communications | |
Neurocutaneous fistula | S. aureus, S. epidermidis, E. coli : meningitis |
Neuroenteric fistula | Gram-negative bacteria: meningitis |
Otic, facial sinus-meningeal sinus tract | Pneumococcus: meningitis |
Facial sinus fracture (CSF rhinorrhea) | Pneumococcus: meningitis |
Intravenous Drug Abuse | S. aureus, P. aeruginosa, streptococci: endocarditis, osteomyelitis Hepatitis B, C, D viruses: AIDS |
Prosthetic Devices | |
Cardiac valves | S. epidermidis, streptococci, S. aureus , diphtheroid, Candida species: endocarditis |
Pacemaker | S. epidermidis, S. aureus, Candida species: subcutaneous pocket or endocardial infection |
Chronic Disease | |
Malnutrition | Measles; tuberculosis; herpes simplex virus; bacterial, parasitic, and viral diarrhea, gram-negative bacteria: sepsis, pneumonia |
Cystic fibrosis | S. aureus, Haemophilus influenzae, mucoid P. aeruginosa, Burkholderia cepacia; pneumonia |
Diabetes mellitus | Urinary tract infections, Mucor, and other fungi: sinus-orbital infection |
Nephrotic syndrome | Pnemococcus, E. coli: peritonitis |
Uremia | S. aureus, gram-negative bacteria, fungi: sepsis, soft tissue infection |
Cirrhosis, ascites | Pnemococcus, E. coli: peritonitis |
Prolonged broad-spectrum antibiotic therapy | Candida species, Enterococcus species, multidrug-resistant gram-negative or gram-positive bacteria: sepsis |
Spinal cord injury | Gram-negative or gram-positive bacteria: pneumonia, pyelonephritis, pressure sores, abscesses, osteomyelitis |
Sickle cell anemia | Pnemococcus: sepsis, meningitis, osteoarticular infection |
Salmonella species, S. aureus: osteomyelitis | |
Congenital heart disease | S. aureus, Streptococcus viridans group: endocarditis |
Urinary tract anomaly | E. coli, S. saprophyticus, Enterococcus species: pyelonephritis |
Kartagener syndrome (dysmotile cilia) | H. influenzae, Moraxella catarrhalis, pnemococcus: pneumonia, sinusitis |
Eczema/atopic disease | S. aureus, Streptococcus species, varicella, herpes simplex, molluscum: cutaneous infection, cellulitis |
Protein-losing enteropathy (lymphangiectasia) | Pneumococcus: sepsis, peritonitis |
Giardia species: diarrhea | |
Periodontitis | Fusobacterium species: cellulitis, facial space infection |
Although there are no established rules regarding immunologic work-up of a patient with infections, an evaluation should be considered for at least 1 of the following: (1) more than 2 systemic bacterial infections (sepsis, meningitis, osteomyelitis); (2) 2 or more serious respiratory infections (pneumonia, sinusitis) or bacterial infections (cellulitis, draining otitis media, lymphadenitis) per year; (3) the presence of an infection at an unusual site (hepatic or brain abscess); (4) infections with unusual pathogens ( Aspergillus pneumonia, disseminated candidiasis, or infection with Serratia marcescens , Nocardia species, or Burkholderia cepacia ); (5) infections of unusual severity; and (6) recurrent mycobacterial infections or invasive infections with atypical mycobacteria.
History and Physical Examination
History
The clinician must determine (1) the frequency, location, severity, and complications of the infections; (2) the accuracy of how infections were documented; (3) the presence or absence of a symptom-free interval; (4) the microbiologic features of any isolate; and (5) the response to antibiotic therapy. A single chronic infection may wax and wane with intermittent, inadequate treatment and may manifest as a series of infections. Furthermore, a detailed history can elucidate other risk factors for recurrent infections. Many nonimmune disorders are characterized by an increased susceptibility to infection that must also be considered (see Table 41.3 ). A detailed history can provide clues as to the likelihood and nature of a primary immune deficiency ( Table 41.4 ).
Suggestive of B Cell Defect (Humoral Immunodeficiency) |
|
Suggestive of T Cell Defect (Combined Immunodeficiency) |
|
Suggestive of Macrophage Dysfunction |
|
Congenital Syndromes with Immunodeficiency |
|
Suggestive of Asplenia |
|
Perinatal History
The clinician should determine if there was exposure to maternal viral infection during gestation (human immunodeficiency virus [HIV], cytomegalovirus (CMV), herpes simplex virus, rubella), or a history of prematurity, blood transfusions, respiratory distress syndrome (with bronchopulmonary dysplasia), or other pertinent neonatal illnesses. Infants previously placed on ventilators may develop chronic obstructive lung disease (bronchopulmonary dysplasia), predisposing them to recurrent pulmonary infections. Most perinatal HIV infections are seen in children whose mother or mother’s partner has engaged in high-risk behavior (i.e., multiple sex partners or use of cocaine or intravenous drugs). Attention should be paid to the time of umbilical cord separation since infants with a history of delayed umbilical cord separation and recurrent episodes of sepsis or pneumonia should be evaluated for leukocyte adhesion deficiency .
Medical History
A variety of nonimmune medical issues can result in recurrent infections (see Table 41.3 ). Approximately 30% of children with recurrent sinopulmonary symptoms can be categorized as atopic (allergic on a hereditary basis). These subjects have normal growth and development, and episodes of recurrent illness may be afebrile, respond poorly to antibiotics, and be accompanied by upper respiratory symptoms such as coughing, sneezing, or wheezing. There may be a family history of atopic disease, and the patient’s past medical history may include episodic wheezing, protracted cough after upper respiratory tract infection (URI) hay fever, allergies to foods, or eczema. The physical examination of allergic school-aged children may reveal typical characteristics including the following: dark circles under the eyes; open mouth with dry lips; coated tongue; evidence of nasal obstruction; transverse nasal crease; boggy, pale nasal mucosa; mucus in the pharynx; posterior pharyngeal “cobblestoning”; and postnasal drip.
Malnutrition and specific vitamin deficiencies may alter immune cell function. Protein-losing states due to gastrointestinal (e.g., inflammatory bowel disease, protein-losing enteropathy) or renal disease (e.g., nephrotic syndrome) may lead to hypocomplementemia, hypogammaglobulinemia, and recurrent infections. Chronic treatment with corticosteroids and other immunosuppressants can result in acquired immunodeficiency and recurrent infections.
Anatomic Abnormalities
Recurrent infections in primary immune deficiencies typically affect different anatomic locations. Structural or anatomic defects often result in recurrent infections that are generally localized to the affected organ system. Approximately 10% of children with recurrent infections have an underlying chronic disease or a structural defect that predisposes them to recurrent infections (see Table 41.3 ).
Eustachian tube abnormalities or cleft palate result in recurrent or chronic otitis media; congenital heart disease results in an increased risk of endocarditis; and posterior urethral valves, vesicoureteral reflux, or ureteral pelvic junction obstruction results in recurrent urinary tract infections. Recurrent pneumonia may result from congenital malformations (trachea-esophageal fistulas, cystic adenomatoid malformation, or sequestration), from aspiration of a foreign body (peanut, small toys) or chronic aspiration (gastroesophageal reflux or swallowing disorders), and from bronchopulmonary dysplasia. Repeated pneumonias in dependent lobes warrant evaluation for recurrent aspiration. Chronic illnesses that result in recurrent pulmonary infections include cystic fibrosis, primary ciliary dyskinesia, or α 1 -antitrypsin deficiency. Recurrent sinus infections can occur due to anatomic defects of the sinuses (polyps, stenotic os). Endotracheal intubation predisposes the patient to recurrent pulmonary infections with nosocomial organisms. Right middle lobe syndrome and sequestered lung can appear as recurrent pneumonia in the same anatomic location.
Any direct communication to the cerebrospinal fluid that bypasses the blood–brain barrier predisposes patients to a central nervous system infection. Basilar skull fractures and dermal sinus tracts or fistulas may communicate with the subarachnoid space or neural tissue. Other conditions predisposing patients to opportunistic infections of the central nervous system include penetrating foreign body, cerebrospinal fluid shunts, myelomeningocele, and encephalocele. Local infections of the sinuses or of the middle ear may spread to contiguous structures to form cerebral abscesses or subdural-epidural empyema. Intravenous drug abuse, bacterial endocarditis, and heart disease with right-to-left shunt are associated with an increased risk of central nervous system infections.
Family History
Specific patterns of inheritance have been determined for a variety of immunologic defects. Genetic defects of immunity can be inherited as X-linked, autosomal recessive, or autosomal dominant disorders. Monogenic primary immunodeficiencies may exhibit reduced penetrance (some people with the genetic abnormality do not exhibit a clinical phenotype) and variable expressivity (different signs and symptoms with same genetic defect). A family history of unexplained infant deaths or serious infection should be sought, particularly in male infants since a number of important immune deficiencies are X-linked. Evidence of consanguinity should be sought as many serious primary immune deficiencies are autosomal recessive. Since allergic diseases can appear as recurrent infections, a family history of atopy is important. A child who has 1 allergic parent or 2 allergic parents is predisposed to allergic reactions by 25% and 50%, respectively.
Environmental History
The incidence of respiratory disease is increased in children exposed to cigarette or marijuana smoke or other noxious fumes (wood-burning stove) in the home. Respiratory and dermatologic findings are seen as a result of exposure to environmental allergens and toxins. Specific bacteriologic and parasitic exposures are associated with certain pets (i.e., Salmonella organisms and iguanas or turtles; psittacosis and birds; Bartonella organisms in kittens). A travel history may suggest exposure to unusual organisms that are regionally endemic, such as certain parasites and specific insect or animal bites, or to contaminated water. A move to a new house or to a new nursery school or exposure to a new babysitter, pet, or housekeeper may suggest possible allergic and infectious risks.
Physical Examination
The physical examination may provide important clues to the diagnosis of a primary immune deficiency (see Table 41.4 ). Longitudinal evaluation of height and weight are crucial in identifying infants with failure to thrive or acute weight loss. Chronic upper respiratory infections are suggested by scarred tympanic membranes, postnasal drip, and cervical adenopathy. Transverse nasal creases, circles under the eyes, and posterior pharyngeal “cobblestoning” suggest respiratory allergy. Recurrent cough, wheezing, digital clubbing, and chest deformity are suggestive of pulmonary disease. Mouth ulceration or stomatitis can be a sign of immune deficiency or autoinflammatory disorder. Auscultation of the apex of the heart in the right side of the thorax (dextrocardia) may be accompanied by ciliary motility abnormalities or asplenia. Lymphadenopathy, hepatosplenomegaly, pallor, wasting, and recent weight loss are suggestive of systemic disease. Absence of lymph tissue (tonsils and lymph nodes) is suggestive of a B cell deficiency, while absence of thymic tissue on chest radiograph in an infant is suggestive of T cell deficiency. Parotid enlargement with lymphadenopathy and hepatosplenomegaly is suggestive of HIV infection. Skin abnormalities including alopecia, eczema, pyoderma, and telangiectasia can be important clues. Evidence of hematologic disease, such as pallor, petechiae, and jaundice can be associated with immunodeficiencies. Generalized lymphadenopathy and splenomegaly may be suggestive of HIV disease, a phagocyte disorder with recurrent infections, or a lymphoproliferative disorder.
Diagnostic Categories
The information obtained from the history and physical examination is usually sufficient to make a tentative classification:
- 1.
The patient who is probably healthy.
- 2.
The atopic or allergic patient.
- 3.
The patient with a nonimmunologic defect in host defense (see Table 41.3 ).
- 4.
The patient with hereditary inflammatory disorders ( Table 41.5 ).
TABLE 41.5
Disease
Genetic Defect/Presumed Pathogenesis
Inheritance
Affected Cells
Functional Defects
Associated Features
Familial Mediterranean fever
Mutations of MEFV (lead to gain of pyrin function, resulting in inappropriate IL-1β release)
AR
Mature granulocytes, cytokine-activated monocytes
Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased
Recurrent fever, serositis, and inflammation responsive to colchicine. Predisposes to vasculitis and inflammatory bowel disease
Mevalonate kinase deficiency (hyper 0 IgD syndrome)
Mutations of MVK (lead to a block in the mevalonate pathway). Interleukin-1β mediates the inflammatory phenotype
AR
Affecting cholesterol synthesis; pathogenesis of disease is unclear
Periodic fever and leukocytosis with high IgD levels
Muckle–Wells syndrome
Mutations of NLRP3 (also called PYPAF1 or NALP3) lead to constitutive activation of the NLRP3 inflammasome
AD
PMNs, monocytes
Defect in cryopyrin, involved in leukocyte apoptosis and NF-κB signaling and IL-1 processing
Urticaria, SNHL, amyloidosis
Familial cold autoinflammatory syndrome
Mutations of NLRP3 (see above)
Mutations of NLRP12
AD
PMNs, monocytes
Same as above
Nonpruritic urticaria, arthritis, chills, fever, and leukocytosis after cold exposure
Neonatal-onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA)
Mutations of NLRP3 (see above)
PMNs, chondrocytes
Same as above
Neonatal-onset rash, chronic meningitis, and arthropathy with fever and inflammation
TNF receptor–associated periodic syndrome (TRAPS)
Mutations of TNFRSF1A (resulting in increased TNF inflammatory signaling)
AD
PMNs, monocytes
Mutations of 55-kDa TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF
Recurrent fever, serositis, rash, and ocular or joint inflammation
Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome
Mutations of PSTPIP1 (also called C2BP1) (affects both pyrin and protein tyrosine phosphatase to regulate innate and adaptive immune responses)
AD
Hematopoietic tissues, upregulated in activated T cells
Disordered actin reorganization leading to compromised physiologic signaling during inflammatory response
Destructive arthritis, inflammatory skin rash, myositis
Blau syndrome
Mutations of NOD2 (also called CARD15) (involved in various inflammatory processes)
AD
Monocytes
Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signaling
Uveitis, granulomatous synovitis, camptodactyly, rash, and cranial neuropathies, 30% develop Crohn disease
Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome)
Mutations of LPIN2 (increased expression of the proinflammatory genes)
AR
Neutrophils, bone marrow cells
Undefined
Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders
Early-onset inflammatory bowel disease
Mutations in IL-10 (results in increase of many proinflammatory cytokines)
AR
Monocyte/macrophage, activated T cells
IL-10 deficiency leads to increase of TNFγ and other proinflammatory cytokines
Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis
Early-onset inflammatory bowel disease
Mutations in IL-10RA (see above)
AR
Monocyte/macrophage, activated T cells
Mutation in IL-10 receptor alpha leads to increase of TNFγ and other proinflammatory cytokines
Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis
Early-onset inflammatory bowel disease
Mutations in IL-10RB (see above)
AR
Monocyte/macrophage, activated T cells
Mutation in IL-10 receptor beta leads to increase of TNFγ and other proinflammatory cytokines
Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis
- 5.
The immunodeficient patient.
Patient Who Is Probably Healthy
Many healthy children have repeated minor infections, or have a relatively brief history of repeated infections, or a single prolonged illness from which recovery has been delayed. Most upper respiratory tract infections last less than 7 days, and duration of longer than 14 days is unusual. Most children younger than 1 year who have a large family or who attend daycare develop respiratory or gastrointestinal infections about 6 times during the 1st year of life. The onset of the recurrent infection may coincide with entry into day care, preschool, or kindergarten. The healthy child has normal growth and development before the illness and usually a normal physical examination finding. When a discrepancy exists between the severity of an illness as reported by the parent and the child’s physical appearance, it is often prudent to delay a detailed evaluation until more objective findings are documented by repeat examinations during acute episodes. Laboratory testing might include a complete blood cell count, inflammatory markers (i.e., erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]) to exclude rheumatic disorders or occult infections, and measurement of immunoglobulin levels and vaccine specific titers as a screen. Cultures and imaging of the affected area may provide additional data. With reassurance of the parents, these children recover spontaneously. Simple measures, rather than a complex set of laboratory studies, are often the only treatment required.
Patient with Hereditary Inflammatory Disorders
Autoinflammatory syndromes , formerly known as periodic fever syndromes , are a heterogeneous and ever increasing group of rare inflammatory disorders that manifest with recurrent fevers and/or inflammatory episodes (see Table 41.5 ). Recurrent fevers or inflammation can often be mistaken for recurrent infections. Patients exhibit characteristic physical findings during these episodes, such as fever, various rashes, lymphadenopathy, aphthous stomatitis, arthritis, and serositis with abdominal, chest, or testicular pain. These episodes can be periodic or sporadic, but the characteristic features occur with each episode. Laboratory evaluation may show elevated white blood cell (WBC) counts and elevated inflammatory markers during the episode that typically resolve between episodes. Importantly, infectious work-ups are often repeatedly negative, and the patient is typically well between febrile episodes.
There are also an increasing number of disorders of immune dysregulation that have been described ( Table 41.6 ). Unlike autoinflammatory disorders, these disorders result in a failure to control T and B cell responses, resulting in autoimmunity . These disorders are not typically episodic, and once autoimmunity develops it continues until treated. Many of these disorders are also associated with immune deficiency and recurrent infection, thus patients experience recurrent infections simultaneously with autoimmune manifestations.
Disease | Genetic Defect/Presumed Pathogenesis | Inheritance | Circulating T Cells | Circulating B Cells | Functional Defect | Associated Features |
---|---|---|---|---|---|---|
Perforin deficiency (FHL2) | Mutations in PRF1 ; perforin is a major cytolytic protein | AR | Increased activated T cells | Normal | Decreased to absent NK and CTL activities (cytotoxicity) | Fever, hepatosplenomegaly (HSMG), hemophagocytic lymphohistiocytosis (HLH), cytopenias |
UNC13D/Munc13-4 deficiency (FHL3) | Mutations in UNC13D ; required to prime vesicles for fusion | AR | Increased activated T cells | Normal | Decreased to absent NK and CTL activities (cytotoxicity and/or degranulation) | Fever, HSMG, HLH, cytopenias |
Syntaxin 11 deficiency (FHL4) | Mutations in STX11 , required for secretory vesicle fusion with the cell membrane | AR | Increased activated T cells | Normal | Decreased NK activity (cytotoxicity and/or degranulation) | Fever, HSMG, HLH, cytopenias |
STXBP2/Munc18-2 deficiency (FHL5) | Mutations in STXBP2 , required for secretory vesicle fusion with the cell membrane | AR | Increased activated T cells | Normal | Decreased NK and CTL activities (cytotoxicity and/or degranulation) | Fever, HSMG, HLH, cytopenias |
Chediak–Higashi syndrome | Mutations in LYST , Impaired lysosomal trafficking | AR | Increased activated T cells | Normal | Decreased NK and CTL activities (cytotoxicity and/or degranulation) | Partial albinism, recurrent infections, fever, HSMG, HLH, giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurologic dysfunction |
Griscelli syndrome, type 2 | Mutations in RAB27A encoding a GTPase that promotes docking of secretory vesicles to the cell membrane | AR | Normal | Normal | Decreased NK and CTL activities (cytotoxicity and/or degranulation) | Partial albinism, fever, HSMG, HLH, cytopenias |
SH2D1A deficiency (XLP1) | Mutations in SH2D1A encoding an adaptor protein regulating intracellular signaling | XL | Normal or increased activated T cells | Reduced memory B cells | Partially defective NK cell and CTL cytotoxic activity | Clinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, aplastic anemia, lymphoma, hypogammaglobulinemia, absent iNK T cells |
XIAP deficiency (XLP2) | Mutations in XIAP encoding an inhibitor of apoptosis | XL | Normal or increased activated T cells; low/normal iNK T cells | Normal or reduced memory B cells | Increased T cells susceptibility to apoptosis to CD95 and enhanced activation-induced cell death (AICD) | EBV infection, splenomegaly, lymphoproliferation, HLH, colitis, IBD, hepatitis, low iNK T cells |
IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked | Mutations in FOXP3 , encoding a T cell transcription factor | XL | Normal | Normal | Lack of (and/or impaired function of) CD4+ CD25+ FOXP3+ regulatory T cells (Tregs) | Autoimmune enteropathy, early-onset diabetes, thyroiditis, hemolytic anemia, thrombocytopenia, eczema, elevated IgE, IgA |
CD25 deficiency | Mutations in IL2RA , encoding IL-2Rα chain | AR | Normal to decreased | Normal | No CD4+ C25+ cells with impaired function of Tregs | Lymphoproliferation, autoimmunity. Impaired T cell proliferation |
STAT5b deficiency | Mutations in STAT5B , signal transducer, and transcription factor, essential for normal signaling from IL-2 and IL-15, key growth factors for T and NK cells | AR | Modestly decreased | Normal | Impaired development and function of γδ T cells, Tregs, and NK cells, low T cell proliferation | Growth hormone–insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity |
LRBA deficiency | Mutations in LRBA (lipopolysaccharide responsive beige like anchor protein) | AR | Reduced I IgG and IgA in most | Defect CTLA4 expression on surface | Recurrent infections, inflammatory bowel disease, autoimmunity; EBV infections | |
CTLA4 | Mutations or deletions in CLTA4 | AD | Variable | IgG reduced | Hypogammaglobulinemia | Recurrent infections, autoimmune cytopenia, brain inflammation |
APECED (APS-1), autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy | Mutations in AIRE , encoding a transcription regulator needed to establish thymic self-tolerance | AR | Normal | Normal | AIRE/1 serves as checkpoint in the thymus for negative selection of autoreactive T cells and for generation of Tregs | Autoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction, and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata, enteropathy, pernicious anemia |
ALPS–FAS | Germinal mutations in TNFRSF6, encoding CD95/Fas cell surface apoptosis receptor | AR | Increased CD4 − CD8 − TCRα/β double negative (DN) T cells | Normal, low memory B cells | Apoptosis defect FAS mediated | Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and IgA normal or increased, elevated FasL and IL-10, vitamin B 12 |
ALPS–FASLG | Mutations in TNFSF6 , Fas ligand for CD95 apoptosis | AR | Increased DN T cells | Normal | Apoptosis defect FAS mediated | Splenomegaly, adenopathies, autoimmune cytopenias, SLE, soluble FasL is not elevated |
ALPS–caspase 10 | Mutations in CASP10 , intracellular apoptosis pathway | AD | Increased DN T cells | Normal | Defective lymphocyte apoptosis | Adenopathies, splenomegaly, autoimmunity |
ALPS–caspase 8 | Mutations in CASP8 , intracellular apoptosis, and activation pathways | AR | Slightly increased DN T cells | Normal | Defective lymphocyte apoptosis and activation | Adenopathies, splenomegaly, bacterial and viral infections, hypogammaglobulinemia |
FADD deficiency | Mutations in FADD encoding an adaptor molecule interacting with FAS, and promoting apoptosis | AR | Increased DN T cells | Normal | Defective lymphocyte apoptosis | Functional hyposplenism, bacterial and viral infections, recurrent episodes of encephalopathy and liver dysfunction |
Immunodeficient Patient
Approximately 5-10% of children with recurrent infections have an underlying immunodeficiency. Frequently, the onset of infections occurs between the ages of 6 and 12 months, but delays in diagnosis are not uncommon. In addition, certain immune deficiencies such as common variable immunodeficiency disease (CVID) can present in adolescence or young adulthood; thus it is critical to consider immune defects in children of any age. Infections in patients with primary immune deficiencies often vary in type, location, and severity, although sinopulmonary infections are common. Failure to thrive may occur and can be a sign of a serious immune defect. Patients with primary immune defects often require repeated courses of antibiotics or intravenous antibiotics, or may have infections with unusual organisms or exhibit unexpected complications. Such children may respond to antibiotics but become ill when the medications are discontinued.
Diagnostic Approach to the Patient with Recurrent Infections
Patients with recurrent, severe, or unusual infections involving multiple sites or organ systems should be investigated for an immunodeficiency ( Fig. 41.1 ). Initial tests are recommended for patients suspected of a primary immune deficiency, although a variety of immune defects can occur despite normal screening tests. Thus it is recommended that advanced testing be performed in consultation with a clinical immunologist.
A complete blood count with manual differential should always be obtained in the evaluation of any child suspected of immunodeficiency. A neutrophil count below 500/mm 3 might indicate severe congenital neutropenia, cyclic neutropenia, idiopathic neutropenia, marrow failure, or replacement of marrow by leukemia or a tumor if other hematopoietic cell lines are affected. Analysis of the peripheral blood smear is important as this can detect neutrophil abnormalities (e.g., abnormal granules in Chédiak-Higashi) or evidence of asplenia (i.e., Howell-Jolly bodies).
Serum immunoglobulin levels (IgG, IgA, IgM, IgE) are essential to the work-up of suspected primary immunodeficiency. Antibody levels vary with age, with normal adult values of IgG at birth from transplacental transfer of maternal IgG, a physiologic nadir occurring between 3 and 6 months of age, and a gradual increase to adult values over several years. IgA and IgM are low at birth and levels increase gradually over several years, with IgA taking the longest to reach normal adult values. When IgG levels are low, albumin levels should be measured because increased loss of proteins, as in protein-losing enteropathy or nephrotic syndrome, can result in hypogammaglobulinemia. High immunoglobulin levels suggest intact B cell immunity and can be found in diseases with recurrent infections, such as chronic granulomatous disease (CGD), immotile cilia syndrome, cystic fibrosis, HIV infection, autoimmune diseases (lupus), and other disorders leading to chronic inflammation. Elevated IgE levels can be found in a number of immune deficiencies such as hyper-IgE syndrome, but more likely represent atopic diseases (atopic dermatitis).
Specific antibody titers after childhood vaccination (tetanus, diphtheria, Haemophilus influenzae type b, or Streptococcus pneumoniae ) reflect the capacity of the immune system to synthesize specific antibodies and to develop memory B cells. If titers are low, immunization with a specific vaccine and obtaining titers 4-6 weeks later should be performed to confirm a response to the immunization. Poor response to bacterial polysaccharide antigens is often found before 24 months of age; even in older individuals the antibody response to polysaccharide vaccines is typically less robust and less long-lived than protein antigens. The development of protein-conjugate polysaccharide vaccines to Streptococcus pneumoniae and Haemophilus influenzae has dramatically reduced invasive infections with these organisms in early childhood by improving the response to vaccination. Antibody responses to the S. pneumoniae serotypes found in the 23-valent polysaccharide vaccine, but not in the conjugate vaccine, can be used to test antibody responses to polysaccharide antigens.
Complement assays include the CH50 test, which measures the presence of proteins in the classical pathway of complement (C1, C2, C3, C4), and the AH50 test, which tests the proteins of the alternative pathway of complement (C3, factor B, properdin). In patients with deficiencies in complement protein, the CH50 levels or AH50 levels are generally zero, whereas they are low but not absent in disorders leading to complement consumption (e.g., systemic lupus erythematosus). If both the CH50 and AH50 levels are abnormal, a defect in the common pathway is likely (C5-C9). Specialized laboratories can measure the presence or function of specific complement proteins.
If the above studies are normal but a primary immune deficiency is still suspected, advanced studies can be performed. One such advanced study is flow cytometry to enumerate the percentage and absolute numbers of T cells, B cells and markers of B cell maturation, and NK cell subsets. Flow cytometry can also test for the presence of surface proteins that are necessary for normal immunity, such as major histocompatibility complex molecules or adhesion molecules. Functional T cell tests include T cell proliferation assays in response to mitogens (phytohemagglutinin or concanavalin A) or antigens (tetanus toxoid or Candida ). These in vitro assays assess the capacity of T cells to proliferate in response to a nonspecific stimulus (mitogens) or antigen-specific memory T cells (antigens). T cell proliferation in response to specific antigens requires a prior exposure to that unique antigen. Delayed-type hypersensitivity skin tests to protein antigens such as tetanus, diphtheria, Candida, or mumps demonstrate the presence and function of both antigen-specific T cells and antigen-presenting cells. If delayed-type hypersensitivity skin test results are negative, one may consider a booster vaccination and retesting 4 weeks later.
Tests for neutrophil function include the nitroblue tetrazolium (NBT) or dihydrorhodamine 123 (DHR) test for CGD. In the NBT test, oxygen radicals generated by activated neutrophils oxidize NBT to an insoluble dark blue dye that can be detected in neutrophils by microscopic examination. In the DHR test, oxygen radicals generated by activated neutrophils oxidize DHR, which results in the emission of light that is detected by flow cytometry. Neutrophils that are activated in patients with CGD cannot generate oxygen radicals and therefore have an abnormal NBT test (no blue neutrophils) or DHR test (no increase in light emitted from activated neutrophils).
Genetic testing to confirm the diagnosis of a primary immunodeficiency disease can be performed in specialized laboratories and may be helpful for deciding on a course of treatment, determining the natural history and prognosis of the disease, and to allow for genetic counseling. Chromosomal deletion/duplication microarrays are increasingly used to diagnose specific syndromic disorders that may have immunodeficiency due to genomic copy number variants (CNV) such as DiGeorge Syndrome. Specific gene or multiple gene sequencing is available commercially. With the advent of next generation sequencing techniques, it is now possible to sequence nearly all the genes in a subject. Because there are hundreds of genes known to cause primary immune deficiencies, this technology is being used in the diagnosis of primary immune deficiencies.